home / stock / wint / wint news

WINT News and Press, Windtree Therapeutics Inc. From 02/28/23

Stock Information
Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com
Menu
WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...
WINT - Windtree Announces Publication on its SERCA2a Activator Drug Candidate for Chronic and Acute Heart Failure

WARRINGTON, Pa., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, announced that its preclinical st...
WINT - Windtree Announces Istaroxime Scientific Abstract Has Been Accepted at the 2023 Technology and Heart Failure Therapeutics Conference

WARRINGTON, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, is targeting cardiogenic shock as a potent...

WINT - Windtree Therapeutics Announces Issuance of New Istaroxime Patent from U.S. Patent and Trademark Office

WARRINGTON, Pa., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today announced that the United S...

WINT - Windtree Therapeutics announces 1-for-50 reverse stock split

Windtree Therapeutics ( NASDAQ: WINT ) board approved a 1-for-50 reverse stock split of its issued and outstanding common stock, effective Feb.24 after market opens. The stock will commence trading under the same symbol. The company expects the reverse stock split, approv...
WINT -  Windtree Therapeutics to Raise $1.0 Million From the Exercise of Previously Issued Warrants

WARRINGTON, Pa., Jan. 20, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NASDAQ: WINT) (“Windtree” or the “Company”) today announced it has entered into warrant inducement offer letters (the “Inducement Offer Letters”) to raise approximately $...

WINT - Nasdaq Grants Windtree Therapeutics 180-day Extension to Regain Compliance

WARRINGTON, Pa., Dec. 05, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today announced that the NASDAQ S...

WINT - Windtree TherapeuticS GAAP EPS of -$0.13 beats by $0.13

Windtree TherapeuticS press release ( NASDAQ: WINT ): Q3 GAAP EPS of -$0.13 beats by $0.13 . As of September 30, 2022, the Company reported cash and cash equivalents of $8.4 million, which is expected to be sufficient to fund operations into the second quarter of 2023....
WINT - Windtree Therapeutics Reports Third Quarter 2022 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for cardiovascular disorders, today reported financial results for the third quarter ended September 30, 2022 and p...

WINT - Windtree receives US patent for istaroxime to treat acute heart failure

Windtree Therapeutics ( NASDAQ: WINT ) said on Tuesday the United States Patent and Trademark Office (USPTO) had issued a new patent for istaroxime administration, an investigational drug candidate in early cardiogenic shock and acute heart failure. The company sa...

WINT - Windtree Announces Notice of Allowance from the US Patent and Trademark Office for a New Istaroxime Patent

WARRINGTON, Pa., Oct. 25, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular disorders, today reported that the United States Patent and Trademark Office (USPTO) has i...
Previous 10 Next 10